Wedbush maintains Ultragenyx Pharma neutral, cuts $23 target
Wedbush maintains a neutral rating on Ultragenyx Pharma and cuts its price target to $23.00 from $30.00,
Ratings actions GMT) Ultragenyx Pharma Price Target Cut to $23.00/Share From $30.00 by WedbushRatings actions